TriNetX Global Collaborative Network

Company

Related News

GLP-1 Drugs Show Protective Effects Against Addictions, Parkinson's, and Endometrial Cancer

Mar 05, 2026

New research reveals GLP-1 receptor agonists reduce substance use disorders by 14%, lower Parkinson's disease risk after 5-10 years of use, and cut endometrial cancer risk by 66% when combined with progestin therapy.

Endometriosis Linked to Higher Risk of Thyroid Disorders; ACOG Issues New Diagnostic Guidance

Mar 03, 2026

Women with endometriosis face increased long-term risk for thyroid disorders including hypothyroidism and Graves disease, according to a 20-year retrospective study. ACOG released new clinical guidance aimed at reducing diagnostic delays through clinical diagnosis and earlier treatment initiation.